Hyperphosphatemia
6 treatments and conditions followed through the public trial records. Not medical advice.How a status is set
Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| AP306 100 mg TID for hyperphosphatemia | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| AP306 125 mg BID for hyperphosphatemia | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| AP306 125 mg TID for hyperphosphatemia | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| AP306 150 mg BID for hyperphosphatemia | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| AP306 75 mg BID for hyperphosphatemia | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| AP306 75 mg TID for hyperphosphatemia | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |